References
- ArcherDFTissue-selective estrogen complexes: a promising option for the comprehensive management of menopausal symptomsDrugs Aging20102753354420583848
- MaartensLWLeusinkGLKnottnerusJAClimacteric complaints in the communityFam Pract20011818919411264270
- LewisVUndertreatment of menopausal symptoms and novel options for comprehensive managementCurr Med Res Opin2009252689269819775194
- GeukesMvan AalstMPNautaMCEThe impact of menopausal symptoms on work abilityMenopause20121927828221997498
- GoldEBSternfeldBKelseyJLRelation of demographic and lifestyle factors to symptoms in a multi-racial/ethnic population of women 40–55 years of ageAm J Epidemiol200015246347310981461
- DennersteinLDudleyECHopperJLA prospective population-based study of menopausal symptomsObstet Gynecol20009635135810960625
- Al-AzzawiFHabibaMRegular bleeding on hormone replacement therapy: a myth?Br J Obstet Gynaecol19941016616627947498
- Limouzin-LamotheMAWhat women want from hormone replacement therapy: results of an international surveyEur J Obstet Gynecol Reprod Biol199664SupplS21S248732469
- Pfizer Pharmaceuticals IncPremPro package insert Available from: http://labeling.pfizer.com/showlabeling.aspx?id=133Accessed October 11, 2011
- PerssonIThurfjellEHolmbergLEffect of estrogen and estrogen-progestin replacement regimens on mammographic breast parenchymal densityJ Clin Oncol199715320132079336356
- LeeEInglesSABergVDProgestogen levels, progesterone receptor gene polymorphisms, and mammographic density changes: results from the Postmenopausal Estrogen/Progestin Interventions Mammographic Density StudyMenopause20121930231022105149
- BrowerVHoming in on mechanisms linking breast density to breast cancer riskJ Natl Cancer Inst201010284384520530764
- KerlikowskeKCookAJBuistDSMBreast cancer risk by breast density, menopause, and postmenopausal hormone therapy useJ Clin Oncol2010283830383720644098
- CrandallCJAragakiAKCauleyJABreast tenderness and breast cancer risk in the estrogen plus progestin and estrogen-alone women’s health initiative clinical trialsBreast Cancer Res Treat201213227528522042371
- HaasJSKaplanCPGerstenbergerEPKerlikowskeKChanges in the use of postmenopausal hormone therapy after the publication of clinical trial resultsAnn Intern Med200414018418814757616
- KommBA new approach to menopausal therapy: the tissue selective estrogen complexReprod Sci20081598499219088368
- LoboRAPinkertonJVGassMLEvaluation of bazedoxifene/conjugated estrogens for the treatment of menopausal symptoms and effects on metabolic parameters and overall safety profileFertil Steril2009921025103819635615
- PinkertonJVUtianWHConstantineGDOlivierSPickarJHRelief of vasomotor symptoms with the tissue-selective estrogen complex containing bazedoxifene/conjugated estrogens: a randomized, controlled trialMenopause2009161116112419546826
- KaganRWilliamsRSPanKMirkinSPickarJHA randomized, placebo- and active-controlled trial of bazedoxifene/conjugated estrogens for treatment of moderate to severe vulvar/vaginal atrophy in postmenopausal womenMenopause20101728128919779382
- PinkertonJVTaylorHPanKChinesAMirkinSBreast parameters with bazedoxifene/conjugated estrogens in randomized, controlled trials of postmenopausal womenMenopause20101712211222
- MacLennanAHBroadbentJLLesterSMooreVOral oestrogen and combined oestrogen/progestogen therapy versus placebo for hot flushesCochrane Database Syst Rev20044CD00297815495039
- UtianWYuHBobulaJMirkinSOlivierSPickarJHBazedoxifene/conjugated estrogens and quality of life in postmenopausal womenMaturitas20096332933519647382
- de VilliersTJBazedoxifene: a novel selective estrogen receptor modulator for postmenopausal osteoporosisClimacteric20101321021820184423
- PickarJHYehI-TBachmannGSperoffLEndometrial effects of a tissue selective estrogen complex containing bazedoxifene/conjugated estrogens as a menopausal therapyFertil Steril2009921018102419635613
- ArcherDFLewisVCarrBROlivierSPickarJHBazedoxifene/conjugated estrogens (BZA/CE): incidence of uterine bleeding in postmenopausal womenFertil Steril2009921039104419635614
- ChlebowskiRTHendrixSLLangerRDInfluence of estrogen plus progestin on breast cancer and mammography in healthy post-menopausal womenJAMA200328932343253
- Pfizer Pharmaceuticals IncPremarin US Package Insert Available from: http://labeling.pfizer.com/showlabeling.aspx?id=131Accessed December 13, 2011
- LoboRABushTCarrBRPickarJHEffects of lower doses of conjugated equine estrogens and medroxyprogesterone acetate on plasma lipids and lipoproteins, coagulation factors, and carbohydrate metabolismFertil Steril200176132411438314